News
Xalud Therapeutics Doses First Patient in Phase 2a Trial of XT-150 for the Treatment of Facet Joint Osteoarthritis Pain March 02, 2022 08:00 AM Eastern Standard Time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback